Behcet DiseaseNCT07702149
Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus
A study testing diet restriction in people with Behcet Disease and Obesity, run by Cairo University at 2 sites in Egypt.
Trial summary
otogic problems are varied in bechet disorder, tinnnitus is one of these problems. obesity may increase this probelm Read more about this study
- Who is it for?
- Ages 40 to 55 years
- Conditions the study is for
- Behcet Disease, Obesity, Subjective Tinnitus
- What is being tested?
- diet restriction
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 2 sitesEgypt
- Study dates
- 4 Jun 2026to 10 Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- behcet disease
- obesity
- subjective tinnitus (bilateral)
Who cannot join
- other autoimune diseases
- refusal to participate
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt2 sites, 2 recruiting
- Recruiting
Cairo University
Dokki, Giza Governorate, 11432
ali AM Ismail, lecturer, +201005154209, ali.mohamed@pt.cu.edu.eg
- Recruiting
Cairo University
Giza, Dokki
ali ismail, lecturer, 02 01005154209, ali.mohamed@pt.cu.edu.eg
About this study
otogic problems are varied in bechet disorder, tinnnitus is one of these problems. obesity may increase this probelm
Read the detailed description
Forty subjects with behcet disorder, excess weight, complaint o tinnnitus will divided to group I or group II. low caorie diet 12-week regeim wil be followed by 20-patient group I . the 20-patient group II will be waitlist.
- Conditions
- Behcet Disease, Obesity, Subjective Tinnitus
- Being tested
- diet restriction
- Medical subject headings
- Behcet Syndrome, Obesity, Tinnitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
diet restrictionBehavioural
twenty subjects with behcet disorder, excess weight, complaint o tinnnitus will follow low calorie diet 12-week regeim.
| Study group | Role | What they receive |
|---|---|---|
| group number 1 | Experimental | twenty subjects with behcet disorder, excess weight, complaint o tinnnitus will follow low caorie diet 12-week regeim Receives: Behavioral: diet restriction |
| group number 2 | No intervention | twenty subjects with behcet disorder, excess weight, complaint o tinnnitus will will be waitlist without intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
tinnitus handicap inventory
it will assess life quality
Measured: it will be measured after 12 weeks
Secondary outcomes (10)
visual analog scale of severity of complint of tinnitus
it will assess severity of complint of tinnitus
Measured: It will be measured after 12 weeks
visual analog scale of discomfort induced by complint of tinnitus
it will assess discomfort induced by complint of tinnitus
Measured: It will be measured after 12 weeks
tinnitus reaction scale
it assess psychaological stressful satus
Measured: It will be measured after 12 weeks
waist circumfereence
it will be assessed at level of umbilicus
Measured: it will be measured after 12 weeks
body mass index
it will be assessed on empty bladder and bowel
Measured: It will be measured after 12 weeks
sate trait anxiety inventory
questionnaire will assess anxiety
Measured: It will be measured after 12 weeks
beck depression scale
it wil assess depression level
Measured: It will be measured after 12 weeks
satifiaction with life scale
it will assess level of satisfaction with life
Measured: It will be measured after 12 weeks
behcet diseae life quality scale
it will assess life quality in relation to behcet disease
Measured: It will be measured after 12 weeks
insomnia severity index
questioanire will assess sleep quality
Measured: It will be measured after 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jul 2026
- Study start4 Jun 2026
- Primary completion10 Sep 2026 (estimated)
- Study completion10 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Behcet DiseaseStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ali Mohamed Ali ismail, Cairo University
- Investigators
- Ali MA Ismail, lecturer, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07702149
- Sponsor's protocol ID
- IRB00014233-87
- Status last verified
- Jul 2026
- First submitted
- 9 Jul 2026
- Last updated
- 14 Jul 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus
- ClinicalTrials.gov ID
- NCT07702149
- Acronym / sponsor ID
- IRB00014233-87
- Conditions
- Behcet Disease, Obesity, Subjective Tinnitus
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 4 Jun 2026 (actual)
- Primary completion
- 10 Sep 2026 (estimated)
- Study completion
- 10 Sep 2026 (estimated)
- First posted
- 14 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
otogic problems are varied in bechet disorder, tinnnitus is one of these problems. obesity may increase this probelm
Detailed description
Forty subjects with behcet disorder, excess weight, complaint o tinnnitus will divided to group I or group II. low caorie diet 12-week regeim wil be followed by 20-patient group I . the 20-patient group II will be waitlist.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| group number 1 | Experimental | Behavioral: diet restrictiontwenty subjects with behcet disorder, excess weight, complaint o tinnnitus will follow low caorie diet 12-week regeim |
| group number 2 | No intervention | –twenty subjects with behcet disorder, excess weight, complaint o tinnnitus will will be waitlist without intervention |
Who may qualify
- Ages
- 40 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- behcet disease
- obesity
- subjective tinnitus (bilateral)
Key exclusion criteria (2 listed)
- other autoimune diseases
- refusal to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| diet restrictiontwenty subjects with behcet disorder, excess weight, complaint o tinnnitus will follow low calorie diet 12-week regeim. | Behavioural | group number 1 |
Primary outcome
tinnitus handicap inventory
Time frame: it will be measured after 12 weeks
it will assess life quality
10 secondary outcomes
visual analog scale of severity of complint of tinnitus
Time frame: It will be measured after 12 weeks
visual analog scale of discomfort induced by complint of tinnitus
Time frame: It will be measured after 12 weeks
tinnitus reaction scale
Time frame: It will be measured after 12 weeks
waist circumfereence
Time frame: it will be measured after 12 weeks
body mass index
Time frame: It will be measured after 12 weeks
sate trait anxiety inventory
Time frame: It will be measured after 12 weeks
beck depression scale
Time frame: It will be measured after 12 weeks
satifiaction with life scale
Time frame: It will be measured after 12 weeks
behcet diseae life quality scale
Time frame: It will be measured after 12 weeks
insomnia severity index
Time frame: It will be measured after 12 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jul 2026.
Related trials for Behcet Disease
RecruitingPhase 3
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Behçet's Disease, Juvenile Psoriatic Arthritis
RecruitingObservational study
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
Not yet recruitingObservational study
Serum EBI-3 Protein Levels in Behçet's Disease
Behçet Disease
Not yet recruitingPhase 2
Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.
Behçet's Syndrome, Behçet's Syndrome (BS)
RecruitingPhase 2
Baricitinib in the Treatment of Intestinal Behçet's Syndrome
Behcet Syndrome, Intestinal Type
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ali MA Ismail, lecturer principal investigator
Cairo University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing diet restriction in people with Behcet Disease and Obesity, run by Cairo University at 2 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ali MA Ismail, lecturer (01005154209, ali.mohamed@pt.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
tinnitus handicap inventory (time frame: it will be measured after 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.